(Q36905876)

17 August 2017

1 reference

title

Depot antipsychotic medications in bipolar disorder: a review of the literature (English)

1 reference

17 August 2017

1 reference

Bond DJ

1

1 reference

17 August 2017

Pratoomsri W

series ordinal

2

1 reference

17 August 2017

Yatham LN

series ordinal

3

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Acta psychiatrica Scandinavica. Supplementum

17 August 2017

published in

1 reference

17 August 2017

issue

434

1 reference

17 August 2017

page(s)

3-16

1 reference

The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Patient and physician attitudes toward lithium: relationship to compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Completed suicide and recent lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

A meta-analysis of the use of typical antipsychotic agents in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Enhancement of treatment adherence among patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

Lithium use and discontinuation in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01054.X

10.1111/J.1600-0447.2007.01054.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference